Wheeldon D R, Potter C D, Oduro A, Wallwork J, Large S R
Transplant Unit, Papworth Hospital, Papworth Everard, Cambridge, United Kingdom.
J Heart Lung Transplant. 1995 Jul-Aug;14(4):734-42.
Donor management remains one of the most neglected areas of transplantation. A comprehensive donor management regimen has been developed. The results of the application of this strategy form the basis of this report.
Full hemodynamic data were collected from 150 multiorgan donors between October 1990 and August 1993. The data were collected at the time of donor team arrival, after insertion of a pulmonary artery floatation catheter and immediately before cardiac excision.
Fifty-two donors (35%) fell well outside our minimum acceptance criteria on arrival. Twenty-one of fifty-two had a mean arterial pressure less than 55 mm Hg (mean 47 mm Hg) despite inotropic support in most cases; 10 of 52 had a central venous pressure greater than 15 mm Hg (mean 18.0 mm Hg); 2 of 52 had a high inotrope requirement greater than 20 micrograms/kg/min (mean 25 micrograms/kg/min). After the insertion of a pulmonary artery floatation catheter, an additional 13 of 52 donors were found to have a pulmonary capillary wedge pressure greater than 15 mm Hg (mean 19.8 mm Hg), and the final 6 of 52 had a low left ventricular stroke work index, less than 15 gm (mean 12.8 gm). After optimal management, including hormone replacement 44 of 52 donors yielded transplantable organs (29 hearts, 15 heart and lung blocks). Thirty-seven of forty-four patients (84%) were alive and well from 13 to 48 months after transplantation. There were five early deaths (11%) caused by infection (heart), adult respiratory distress syndrome (heart), arrhythmia (heart), cerebrovascular event (heart and lung), and infection (heart, lung, and liver). Two late deaths (5%) occurred as a result of tamponade (3 months, heart) and infection (14 months, heart and lung). Eight of fifty-two organs were still unsuitable for transplantation after optimum management during the splanchnic dissection as a result of inotrope dependency (n = 4), left ventricular hypertrophy (n = 2), and coronary artery disease (n = 2).
The data indicate that, of the organs which initially fall outside our transplant acceptance criteria, 92% are capable of functional resuscitation. Conversely, superficial assessment may not show compromised function. Optimizing cardiovascular performance also has important implications for the viability of all transplantable organs. This aggressive approach to donor management has resulted in the transplantation of 44 donor hearts that may otherwise have been turned down or inappropriately managed.
供体管理仍是移植领域最被忽视的方面之一。已制定了一套全面的供体管理方案。本报告以该策略的应用结果为依据。
收集了1990年10月至1993年8月期间150例多器官供体的完整血流动力学数据。这些数据在供体团队到达时、插入肺动脉漂浮导管后以及心脏切除术前即刻收集。
52例供体(35%)在到达时远远超出我们的最低接受标准。52例中有21例平均动脉压低于55 mmHg(平均47 mmHg),多数情况下尽管使用了血管活性药物支持;52例中有10例中心静脉压高于15 mmHg(平均18.0 mmHg);52例中有2例血管活性药物需求量高,大于20微克/千克/分钟(平均25微克/千克/分钟)。插入肺动脉漂浮导管后,52例供体中又有13例被发现肺毛细血管楔压高于15 mmHg(平均19.8 mmHg),52例中的最后6例左心室每搏功指数低,低于15克(平均12.8克)。经过优化管理,包括激素替代,52例供体中有44例获得了可用于移植的器官(29颗心脏,15个心肺联合块)。44例患者中有37例(84%)在移植后13至48个月存活且状况良好。有5例早期死亡(11%),原因分别是感染(心脏)、成人呼吸窘迫综合征(心脏)、心律失常(心脏)、脑血管事件(心肺)以及感染(心脏、肺和肝脏)。2例晚期死亡(5%)分别是由于心包填塞(3个月,心脏)和感染(14个月,心肺)。在最佳管理后,52个器官中有8个在腹腔脏器解剖期间仍因依赖血管活性药物(n = 4)、左心室肥厚(n = 2)和冠状动脉疾病(n = 2)而不适合移植。
数据表明,最初不符合我们移植接受标准的器官中,92%能够实现功能复苏。相反,表面评估可能无法显示功能受损情况。优化心血管功能对所有可移植器官的存活也具有重要意义。这种积极的供体管理方法使得44颗原本可能被拒绝或管理不当的供体心脏得以进行移植。